A reduced-intensity bone marrow transplant regimen provides durable engraftment with low rejection rates and also may preserve fertility, according to researchers at Johns Hopkins Kimmel Cancer Center.
Researchers at the Johns Hopkins Kimmel Cancer Center have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune cells to remain biologically “younger” for longer than normal, predisposing affected individuals to lymphoma and other cancers.
